ACCESS TO MEDICINES WORK IN COUNTRIES

1
ACCESS TO MEDICINES WORK IN COUNTRIES
Uganda Example

• Joseph Mwoga
• WHO Uganda
• Rosette Mutambi
• HEPS

2
WHO - HAI Africa Regional Collaboration for
Action on Essential Medicines in Africa

• Goal Improved equitable and sustainable ATM
• Purpose
• Improved policies and practices
• Collaboration framework (MOH-WHO-CSO)
• Outputs
• Increased participation of CSO's
• Access to quality information, related to
  affordability and availability of medicines in
  selected countries
• Collaboration mechanisms established at global
  level and in selected countries

3
Enhanced expertise in country offices
National Professional Officers Network in Africa

4
Collaboration Management framework

• Programme Management Group
• Country working groups planning, budgeting,
  implementation reporting
• M E tools and mechanisms- quantitative and
  qualitative information

5
Country Working Group (CWG)
HAI (A) Partner
MoH
WHO
Supported by DFID UK
6
Rationale for the Collaboration

• Complementary mandates approaches
• Enhance broad stakeholder participation in policy
  development and implementation
• Empower CSO build capacity in the medicines
  field
• Links between consumers, MOH WHO, shared
  expertise, greater impact
• Improve coordination and efficient use of
  resources
• Build ownership of process products

7
Terms of Reference for CWG

• Joint Planning Implementation
• Develop collaboration work plans (including
  timelines and budgets) for activities
• Mobilize resources for implementation of agreed
  work plans
• Coordinate implementation of joint work plans
• Submit timely periodic activity reports to the
  Project Management Group

8
Collaborative Outputs

• Assessment of the Pharmaceutical Situation in
  Uganda (Baseline Survey 2002 to be repeated
  2007)
• Medicine Prices Survey (2004)
• Monitoring of Medicines Prices (Ongoing)
• Support for the review of the law on patents
  IPR
• Development of IEC materials on Rational Use of
  Medicines (ongoing)

9
Potential for MeTA in Uganda-1

• Monitoring of medicines for prices and include
  quality aspects for different outlet categories
• Support the sharing of information within the
  Medicines Regulation Agency Such as
• Medicines tested and passed
• List of registered medicines
• Different forms and guidelines
• Information obtained through the
  pharmacovigilance and post-market surveillance
  activities
• Support procurement transparency at JMS NMS

10
Potential for MeTA in Uganda-2

• Information Centre for
• Common medicines retail indicative median prices
• Produce Uganda National Formulary based on WHO
  Model Formulary
• Procurement commitments, gaps pipelines
• Pharmaceutical Situation assessments
• Patents IPR
• Promotion of Rational Use of Medicines
• Consumers involvement

11

• Thank You